New patent for Am Regent drug INJECTAFER

Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are ten patents…

The post New patent for Am Regent drug INJECTAFER appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog